Capital Access Advisory Program — Building Companies

For Ontario-based life sciences and health technology startups preparing for their first major fundraising round, access to the right investors and strategic guidance can be just as critical as capital itself. The Capital Access Advisory Program — Building Companies, delivered by the Ontario Bioscience Innovation Organization (OBIO), is designed to help early-stage companies sharpen their strategy and position themselves for Series A financing and meaningful commercialization milestones.

This competitive program runs over roughly nine to twelve months and pairs selected startups with an international steering committee made up of experienced investors, healthcare executives, and sector advisors. Rather than offering a one-size-fits-all approach, the program focuses on practical, company-specific guidance around business strategy, advanced fundraising preparation, financial modeling, and deal execution. Participating companies also benefit from warm introductions to venture capital firms and strategic partners, along with coordinated outreach at major international investment conferences. A key milestone is the opportunity to present at the OBIO Investment Summit, where hundreds of health science companies have connected with global investors and strategic partners.

Well suited for biotechnology and medical technology startups that are transitioning from early traction toward institutional investment, this non-repayable advisory support can significantly accelerate fundraising readiness. Business owners interested in building investor confidence and expanding their capital network will want to explore whether this program aligns with their growth plans and timing.